Ignite Creation Date:
2025-12-25 @ 12:53 AM
Ignite Modification Date:
2026-01-04 @ 5:49 PM
Study NCT ID:
NCT05520567
Status:
RECRUITING
Last Update Posted:
2025-12-17
First Post:
2022-08-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid Leukemia
Sponsor:
Astellas Pharma Global Development, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-01-31
Start Date Type:
ACTUAL
Primary Completion Date:
2028-07-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-07-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-08-26
First Submit QC Date:
None
Study First Post Date:
2022-08-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-16
Last Update Post Date:
2025-12-17
Last Update Post Date Type:
ESTIMATED